Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exscientia Ltd ADR
(NQ:
EXAI
)
5.010
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exscientia Ltd ADR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Exscientia Business and Financial Update for the Full Year 2022
March 23, 2023
From
Exscientia
Via
Business Wire
A Preview Of Exscientia's Earnings
March 22, 2023
Via
Benzinga
Evogene Offers An Excellent Risk/Reward Ratio
March 21, 2023
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...
Via
Talk Markets
Exscientia to Report Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
From
Exscientia plc
Via
Business Wire
Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR
March 15, 2023
From
Exscientia plc
Via
Business Wire
Barclays Maintains Overweight Rating for Exscientia: Here's What You Need To Know
November 16, 2022
Via
Benzinga
Bayer, Exscientia Part Ways On Artificial Intelligence Collaboration
August 18, 2022
Via
Benzinga
Exscientia Announces Expansion of its Precision Oncology Pipeline
March 14, 2023
From
Exscientia plc
Via
Business Wire
Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform
March 07, 2023
From
Exscientia plc
Via
Business Wire
Exscientia to Present at Upcoming Investor Conferences in March
February 22, 2023
From
Exscientia plc
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
February 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 09, 2023
Via
Benzinga
BP, Hertz Global, Take-Two Interactive Software And Other Big Stocks Moving Higher On Tuesday
February 07, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Exscientia Announces First-in-Human Study for Bristol Myers Squibb In-Licensed PKC Theta Inhibitor, EXS4318
February 02, 2023
From
Exscientia plc
Via
Business Wire
US Stocks Open Lower; Dow Drops 125 Points
February 01, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 125 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.37% to 33,960.34 while the NASDAQ fell...
Via
Benzinga
Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress
December 06, 2022
From
Exscientia plc
Via
Business Wire
Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
November 28, 2022
From
Exscientia plc
Via
Business Wire
Exscientia Business and Financial Update for the Third Quarter 2022
November 15, 2022
From
Exscientia plc
Via
Business Wire
Earnings Scheduled For November 15, 2022
November 15, 2022
Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
Via
Benzinga
Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in Developing Novel Oncology Treatments
November 14, 2022
From
Exscientia plc
Via
Business Wire
Exscientia to Report Third Quarter 2022 Financial Results on November 15, 2022
November 08, 2022
From
Exscientia plc
Via
Business Wire
Exscientia Expands Biologics Design Capability with Automated Laboratory
November 03, 2022
From
Exscientia plc
Via
Business Wire
Exscientia to Present at Upcoming Investor Conferences in November
November 01, 2022
From
Exscientia
Via
Business Wire
Exscientia Wins Prix Galien USA 2022 Digital Health Solution Award
October 28, 2022
From
Exscientia plc
Via
Business Wire
Exscientia Presents Novel Patient Stratification and Biomarker Data for GTAEXS-617 at the 34th EORTC-NCI-AACR Annual Symposium
October 26, 2022
From
Exscientia plc
Via
Business Wire
Blood Cancer Discovery Publication Further Validates Exscientia's AI Precision Medicine Platform for Improving Patient Outcomes
September 20, 2022
From
Exscientia
Via
Business Wire
Exscientia Welcomes Caroline Rowland as Chief People Officer
September 08, 2022
From
Exscientia plc
Via
Business Wire
Exscientia to Present at Upcoming Investor Conferences in September
September 07, 2022
From
Exscientia
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
August 19, 2022
Gainers
Via
Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
August 19, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.